Want to join the conversation?
$CME 2Q15 Q&A: Richard of Sandler O'Neill asked about growth initiatives priority. Bryan explains that diversity of the product in asset classes is playing extremely well in our international growth model and as a result we've seen some double-digit growth occurring across the asset classes both throughout Asia as well as within the EMEA sector.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?